Kedem Pharmaceuticals, Inc.(fka KDMP)

[Tombo]

In order for the name change and reverse split to be recognized on the OTC Bulletin Board, the Financial Industry Regulatory Authority ("FINRA") must process the corporate actions. The Company is in the process of submitting the required documentation to FINRA, but will continue to trade under the name Global Health Ventures Inc. and the symbol "GHLV" until such time as FINRA has declared the name change and reverse split effective. Once the process has been completed, the Company will file a current report on Form 8-K to announce the effective date and its new trading symbol.